Animal Extrapolation and the Challenge of Human Heterogeneity
- 1 November 1986
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 75 (11) , 1041-1046
- https://doi.org/10.1002/jps.2600751105
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liverCarcinogenesis: Integrative Cancer Research, 1985
- Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1, 4:6,3-dilactone, an in vivo β-glucuronidase inhibitorCarcinogenesis: Integrative Cancer Research, 1984
- Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strainsJournal of Pharmacy and Pharmacology, 1981
- Metabolism of aflatoxin B1, benzo[a]pyrene, and 1,2‐dimethylhydrazine by cultured rat and human colonTeratogenesis, Carcinogenesis, and Mutagenesis, 1981
- Metabolism of benzo[a]pyrene by cultured tracheobronchial tissues from mice, rats, hamsters, bovines and humansInternational Journal of Cancer, 1980
- A study of the debrisoquine hydroxylation polymorphism in a Nigerian populationXenobiotica, 1980
- N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and DenmarkEnvironmental Health Perspectives, 1979
- β ‐Glucuronidase deficiency: Enzyme studies in an affected family and prenatal diagnosisJournal of Inherited Metabolic Disease, 1978
- Properties of Benzpyrene Hydroxylase from Human Liver and Comparison with the Rat, Rabbit and Guinea-pig EnzymesXenobiotica, 1975
- Induction, activation and inhibition of epoxide hydrase: an anomalous prevention of chlorobenzene-induced hepatotoxicity by an inhibitor of epoxide hydraseChemico-Biological Interactions, 1973